CEO.CA's Inside the Boardroom: Kairos Pharma Might Change Cancer Treatment Forever
Rhea-AI Summary
CEO.CA, an investor social network focused on junior resource and venture stocks, highlights a new episode of its 'Inside the Boardroom' interview series featuring Kairos Pharma (NYSE American: KAPA) Chairman and CEO Dr. John Yu. According to CEO.CA, the discussion centers on Kairos Pharma's lead cancer drug and its approach to addressing tumor resistance, a major challenge in cancer treatment. The feature invites investors to watch the video on YouTube, engage with commentary on CEO.CA's KAPA page, and contact CEO.CA for opportunities to showcase companies in future episodes.
Positive
- None.
Negative
- None.
News Market Reaction – KAPA
On the day this news was published, KAPA declined 6.47%, reflecting a notable negative market reaction. Argus tracked a peak move of +20.4% during that session. Argus tracked a trough of -26.1% from its starting point during tracking. Our momentum scanner triggered 27 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $504K from the company's valuation, bringing the market cap to $7.28M at that time. Trading volume was exceptionally heavy at 122.3x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 04 | pipeline expansion update | Positive | +0.8% | Shareholder letter outlining acquisitions, pipeline growth, and over $8M non-dilutive funding. |
| May 14 | industry award | Positive | +6.1% | Recognition for leadership in drug resistance development and impact on cancer therapeutics. |
| May 13 | conference presentation | Neutral | -4.3% | Notice of LD Micro Invitational appearance to update on clinical and partnering activities. |
| May 08 | governance and filings | Negative | -5.4% | Annual meeting date plus going concern language disclosed in Form 10-K financials. |
| Apr 15 | innovation award | Positive | +0.1% | Pinnacle Award recognition for resistance‑modulating approach centered on ENV‑105. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
KAPA has generally traded higher on positive corporate updates, with only one divergence among the last five news-driven moves.
Key Terms
nyse american financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - July 15, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers.
Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality. Millions of people visit CEO.CA each year to connect with investors from around the world, share knowledge and view impactful stories about stocks, commodities, and emerging companies.
Meet the Executive Shaping the Pharmaceutical Landscape
'Inside the Boardroom' is more than just an interview series - it's a chance to gain firsthand knowledge from industry leaders, understanding their vision, challenges, and strategy.
Cancer drugs stop working because tumors learn to fight back. But what if that resistance could be stopped entirely? We caught up with Dr. John Yu, Chairman & CEO of Kairos Pharma Ltd. (NYSE American: KAPA), to discuss how their lead drug is tackling cancer's biggest defence mechanism.
See what investors have to say about the company: https://ceo.ca/kapa.us
Kairos Pharma
(NYSE American: KAPA)
Tune in to 'Inside the Boardroom' each week and be part of the conversation that's shaping the business landscape. Visit CEO.CA or our YouTube page for hundreds more executive interviews from CEO.CA here.
Interested in showcasing your company on 'Inside the Boardroom'? Get in touch with our team at sales@ceo.ca for further details and opportunities.
About CEO.CA
The leading community for investors & traders in junior resource & venture stocks. CEO.CA is one of the most popular free financial websites and apps in Canada and for small-cap investors globally -- with industry leading audience engagement and mobile functionality. Since 2012, CEO.CA has brought millions of investors together from over 164 countries to discuss their portfolio holdings and find new investment opportunities. Download our App on iOS or Android marketplace or visit us today at CEO.CA to set up your free account.
CEO.CA is a wholly owned subsidiary of EarthLabs, Inc.
For further information please contact:
CEO.CA
Email: hello@ceo.ca
Website: CEO.CA
Neither the TSX Venture Exchange ("TSXV"), OTC Best Market "(OTCQX") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement
The information regarding any issuer contained or referred to in any interviews conducted by CEO.CA has been furnished by such issuer directly, and neither CEO.CA nor any of its affiliates or principals assumes any responsibility for the accuracy or completeness of such information or for any failure by an issuer to ensure disclosure of events or facts which may affect the significance or accuracy of any such information.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This news release contains forward-looking information which involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the objectives, goals, future plans, statements regarding exploration results and exploration and/or development plans of companies featured on the CEO.CA platform. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, capital and operating costs varying significantly from estimates, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, fluctuations in commodity prices, delays in the development of projects, currency risk and the other risks involved in the applicable exploration and development industry, and those risks set out in the public documents of such companies filed on SEDAR or elsewhere from time to time. Undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. CEO.CA disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305244